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There is no effective chemotherapy against diseases caused by Phytomonas sp., a plant trypanosomatid respon-
sible for economic losses in major crops. We tested three triazolo-pyrimidine complexes [two with Pt(II), and another
with Ru(III)] against promastigotes of Phytomonas sp. isolated from Euphorbia characias. The incorporation of
radiolabelled precursors, ultrastructural alterations and changes in the pattern of metabolite excretion were exam-
ined. Different degrees of toxicity were found for each complex: the platinun compound showed an inhibition effect
on nucleic acid synthesis, provoking alterations on the levels of mitochondria, nucleus and glycosomes. These
results, together with others reported previously in our laboratory about the activity of pyrimidine derivatives,
reflect the potential of these compounds as agents in the treatment of  Phytomonas sp.
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The name Phytomonas was proposed by Donovan
(1909) to designate a trypanosome discovered by Lafont
in the same year and initially named Leptomonas davidi.
Phytomonas affects more than 100 plant species in about
12 families, causing diseases in plants of substantial eco-
nomic interest, such as “sudden wilt” in the oil palm and
“Hartrot” disease in the coconut palm, among others
(Dollet 1984).  Phytomonas sp. are distributed primarily in
tropical and subtropical zones, although they have been
described in all continents except the Antarctic (Camargo
& Wallace 1994). Although there is a certain knowledge
about the biology of this protozoan (Camargo 1999), apart
from studies aconducted in our  laboratory (Luque et al.
2000a, b), little information is available on its control.  To
finding of an effective chemotherapy against Phytomonas
spp. has not only a direct economic interest, but since
these parasites present metabolic routes similar to those
of other Trypanosomatidae pathogenic to humans and
animals, they represent also a potential biological model
(Uttaro et al. 1999, Magán et al. 2004).
We have previously demonstrated the biological ac-
tivity of some metal complexes of triazolo-pyrimidine de-
rivatives against Phytomonas staheli, Leishmania do-
novani, and Trypanosoma cruzi, inhibiting the synthesis
of DNA, RNA, and proteins and inducing severe ultra-
structural  damage (Luque et al. 2000a, b,).
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The metal complexes with triazolo-pyrimidine deriva-
tives are ligands that could mimic purines. These com-
pounds have already been reported as growth inhibitors
of some microorganisms (reviewed in Fischer 1993), and
tumoral lineages (Chae et al. 1995, Quintero et al. 1999), by
inhibition of DNA synthesis. Their potential in the treat-
ment of neurodegenerative disorders such as Parkinson’s
disease has also been tested (Baraldi 1996).
In this work, we seek to advance in the development
of an effective chemotherapy by testing three new triazolo-
pyrimidine derivatives on promastigotes of Phytomonas
isolated from Euphorbia characias, investigating their
possible mechanism of action.
MATERIALS AND METHODS
Parasites - The promastigote forms of P. characias
were isolated from E. characias in Montpellier (France)
and kindly provided by Dr M Dollet. The flagellates were
cultured in Grace’s medium at 28ºC in plastic Roux flasks
(Corning, Washington, DC, US) using an initial concen-
tration of 5 x 104 cells/ml. On the fourth day of culture, the
parasites were centrifuged at 1500 g for 10 min and the
pellet was washed twice in PBS. Proliferation of the para-
sites was monitored by counting in a Neubauer chamber.
Compounds assayed -  The compounds used were
termed; SPIV:  Cis [PtCl2 (7HtpO)2] 
. 2H2O;   SPV:  PtCl2
(5HtpO)2
. 2H2O and SPVI: RuCl3 (7HtpO)2
. 2H2O, and
were synthesized by Salas et al. (2001).
The ligand 7 HtpO corresponds to 4,7 dihydro -7-oxo-
[1,2,4] triazolo [1,5-a] pyrimidine and 5 HtpO to 4,5 dihydro
-5- oxo-[1,2,4] triazolo [1,5-a] pyrimidine (Fig. 1).
Dimethyl sulfoxide was used as solvent of the com-
pounds and the final concentration in the experiments
was 0.01% (v/v), which was previously shown not to in-
terfere with parasite growth (Mesa-Valle et al. 1996).
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Macromolecule synthesis by P. characias - The effect
of the compounds on the parasite’s biosynthesis of nucleic
acids and proteins was evaluated by the incorporation of
6-[3H]thymidine (26-30 Ci/mmol), 5-[3H]uridine (25-30 Ci/
mmol) or 4,5-[3H]leucine (35-70 Ci/mmol). All these radio-
labelled compounds were obtained from the Radiochemi-
cal Centre (London, UK). Cultures containing 5 x 106 cells/
ml (total volume 200 ml) were centrifuged, the pellet was
resuspended in 1 ml of culture medium and compounds
was added to give the final concentration of 5 µM. After
incubation at 28ºC for 30 min, the medium was replaced
by a fresh one containing 5 µg/ml of each radioactive
analog. At 0, 45, 75 and 135 min, the cultures were centri-
fuged, and the pellet, after three washes with cold me-
dium, was precipitated with 10% trichloroacetic acid for 2
h at 4ºC. The precipitates were filtered through Whatman
GF/c filters, washed with 5% trichloroacetic acid and then
with 10% ethanol, and dried at 60ºC under infrared lamps.
Once dried, the filters were submerged in scintillation cock-
tail {2,5-diphenyloxazole [PPO], 4 g; 1,4-bis(5-phe-
nyloxazoly)benzene [POPOP], 0.1 g; toluene, 1000 ml}, and
the radioactivity incorporated was determined with a beta-
spectrometer (Beckman model LS 6000TA, Palo Alto, CA,
US). Triplicates were made of each assay and the mean ±
SD was determined (Mesa-Valle et al. 1996).
Ultrastructural alterations - The parasites (5 x 105
cells/ml, volume total 200 ml), were cultured in Grace’s
medium, containing 5 µM of the compounds. After 72 h,
the parasites were centrifuged at 1500 g for 10 min, washed
in fresh medium, and fixed for 2 h in a 2.5% (v/v) solution
of cacodylate-buffered 0.1 M glutaraldehyde containing
0.1 M CaCl2 and 0.9 % NaCl. The fixed cells were washed
in the same buffer and postfixed in isotonic saline solu-
tion containing 1% (v/v) osmiun tetroxide and 0.08% po-
tassium fluorocyanide. After postfixation the cells were
washed in buffer, dehydrated by acetone washes, and
embedded in Epon (Luque et al. 2000b). Thin sections
were stained with uranyl acetate and lead citrate and
exmined with an EMCIO Zeiss transmission electron mi-
croscope.
Metabolite excretion - After the same treatment as
described above, the supernatants were collected to de-
termine the excreted metabolites by nuclear magnetic reso-
nance spectroscopy (1H-NMR) (Sánchez-Moreno et al.
1992). The chemical displacements, expressed in parts per
million (ppm) using sodium 2,2dimethyl-2-silapentane-5-
sulfonate as the reference signal, allowed the identifica-
tion of the metabolites, which were consistent with those
described by Sánchez-Moreno et al. (1992). In all cases,
triplicates were made of each experiment.
RESULTS
Fig. 2 shows the action of the three triazolo-pyrimi-
dine derivatives on the incorporation of the radiolabelled
precursors by the P. characias promastigotes. The incor-
poration of 6-[H3] thymidine was inhibited after 135 h in
79.3% and 83.1 % for, respectively, SPIV and SPV and in
26.5 % for SPVI (Fig. 2A). SPIV and SPV did not interfere
with the incorporation of 4,5-[H3]-leucine, while SPVI led
to an inhibition of  26 % after the same was the only com-
pounds that inhibited (Fig. 2B). The incorporation of 5-
[H3]-uridine by the parasite was inhibited after 135 h in
the range of 25 % to 37.4 % for the three compounds (Fig.
2C).
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Fig. 2: effect of the triazolo-pyrimidine derivatives on the incor-
poration of radiolabelled precursors 6-[3H] thymidine (A), 4.5-
[3H] leucine (B) and 5-[3H] uridine (C) by promastigotes of
Phytomonas characias. All compounds were tested at 5 µM; con-
trol (!); SPIV ("); SPV (!) and SPVI ("); DPM: disintegrations
per min
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The ultrastructure of P. characias promastigotes is
shown in Fig. 3A, revealing their principal organelles and
cell organization typical of members of the family
Trypanosomatidae (Fernadez-Becerra et al. 1997).
Fig. 3B shows the effect of 5 µM SPIV after three days
of treatment. The cell is swollen and roundish. The cyto-
plasm has little electrodensity and has a granular aspect
with many vacuoles, most of which are apparently empty.
Glycosomes are altered, less electrodense and very swol-
len.  The mitochondrion is swollen, with no mitochondrial
cryptal visible.  The kinetoplast has lost its normal com-
pact structure.  The nucleus lacks a uniform nucleolus
but chromatin accumulations were observed associated
with the nuclear membrane, with discontinuous distribu-
tion around the nucleus.
Fig. 3C  reveals the alterations produced by SPV in
promastigote forms of P. characias. The cytoplasm ap-
pears less dense, and large empty vacuoles and cy-
toplasmatic disorganization are evident.  Alterations in
the glycosomes are evident, being granulose and swol-
len. The mitochondrion is also swollen and the kineto-
plast has a disorganized structure.
Fig. 3: ultrastructural effect of triazolo-pyrimidine derivatives (5 µM) on promastigotes of Phytomonas characias cultured in Grace’s
medium for 72 h. A: control; B: SPIV; C: SPV; D: SPVI; EV: empty vacuoles; G: glycosome; K: kinetoplast; M: mitochondrion; MT:
microtubules; N: nucleus;  NM: nuclear membrane; V: vacuoles. Bars = 0.583 µm
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Fig. 3D shows the alterations in P. characias treated
with SPVI. The parasite does not appear swollen on being
treated with SPVI, but the cytoplasm appears to be less
electrodense than in the control parasites. The nucleus
seems also to be altered, with reduction of its contents.
Also, alteration in the kinetoplast can be observed, with a
less compact organization of the kDNA.
The main metabolites excreted by P. characias are, in
ascending order: acetate, ethanol, succinate, glycine and,
in less quantities, L-alanine and lactate (Fig. 4A).
Figs 4B, C, D show the spectra that resulted from the
treatment of P. characias with of the triazolo-pyrimidine
compounds. The SPIV and SPV at  5 µM (Figs 4B, C)
strongly inhibited all the metabolites excreted.  The spec-
trograph corresponding to the effect of SPV (Fig. 4C) in-
dicates an additional peak (at 2.3 ppm) not detected in the
spectrum of untreated parasites, which was identified as
pyruvate. SPVI notably inhibited only the excretion of
acetate (roughly 25%) (Fig. 4D).
DISCUSSION
The chemotherapeutic capacity of the triazolo-pyrim-
idines appear promising for due to their similarities to
purines, prompting us to test the three compounds against
microorganisms. Furthermore, these compounds have
been used as molecular models to study the interactions
of the metal ions with nucleic acids (Ram et al. 1992).  The
two derivatives that carry the Pt(II) in their structures
(SPIV and SPV) inhibit the incorporation of 6-[3H]- thymi-
dine by P. characias, indicating interference in the DNA
synthesis. This effect may be due to the fact that, resem-
bling pyrimidines, these derivatives could intercalate in
DNA, altering its secondary structure. This fact is con-
firmed by the electron microscopy results, which show
Fig. 4: [1H]NMR study of the production of ethanol (ET), lactate (L), L-alanine (AL), acetate (A), pyruvate (P), succinate (S), glycine
(GLY) by promastigote of Phytomonas characias treated with 5 µM of the triazolo-pyrimidine derivatives; A: control; B: SPIV; C: SPV;
D: SPVI
ppm
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that the organization of both DNA and the chromatin are
altered.
SPVI also inhibits, though to a lesser degree, DNA
synthesis and, like the other two derivatives, affects ge-
netic material. A decrease in the incorporation of 5-[3H]-
uridine, indicates a disturbance of RNA synthesis induced
by SPVI. These data, together with those previously gath-
ered by our group (Luque et al. 2000b, Magán et al. 2004),
point to the possibility that one of the possible targets of
the triazolo-pyrimidine derivatives is nucleic acid synthe-
sis. Leucine incorporation was also visibly diminished by
treatment with SPVI, suggesting that this compound can
act directly on protein synthesis (Zollner 1993), or can
indirectly affect ribosomal factors.
Although the ultrastructure analysis does not enable
us to define the mode of action of these compounds
against P. characias, the alterations observed reflect the
beginning of the protozoa’s death. In a same field (data
not shown), parasites showed very different degrees of
alteration.  In this experiment, we use a concentration of 5
µM, because this value is roughly 10-fold lower than that
of IC50 found in prior studies (Salas et al. 2001).
In conclusion the three compounds seem to induce
several alterations in the mitochondrion, nucleus and
glycosomes of these kinetoplastids.  SPIV and SPV pro-
voked very clear alterations not only in the cytoplasm
and organelles, but also in the cell nucleus (mainly SPV).
Both compounds provoked similar alterations which were
more patent than those caused by SPVI.  Swelling of the
parasites was observed only after treatment with SPIV
and SPV.  These complexes could change the osmotic pres-
sure of the parasite, forcing it to regulate the pressure
with respect to the culture medium.  Treatment with SPVI
appears to affect primarily the nucleus although to a lesser
degree it disrupts the normal structure of the kinetoplast.
Due to this results, further studies will be necessary to
determine if this alterations were induced by these com-
pounds.
These effects unquestionably alter the energy metabo-
lism of the promastigote forms of P. characias, as con-
firmed by the biochemical data gathered in the present
work. Change in the excretion of different metabolites is
of great use in elucidating the toxic activity of these com-
pounds, since the catabolism of Phytomonas in general
follows a pattern common among the species or isolates
studied (Sánchez-Moreno et al. 1992, Fernández-Becerra
et al. 1997). In the present work, the main metabolites ex-
creted by P. characias were acetate, ethanol, succinate,
and glycine, in accordance with previous results. Treat-
ment with SPIV or SPV inhibited the excretion of these
catabolites. The reduction of glycine and succinate may
signal an effect on the glyoxalate cycle operating  in
Phytomonas sp. (Sánchez-Moreno et al. 1992), which may
explain pyruvate as a new excreted metabolite, as occurs
with SPV. The decline in acetate may also be due to direct
impact on acetate synthetase, particularly SPVI, which
interferes with protein synthesis. This hypothesis is rein-
forced by electron microscopy data, which indicates a
loss in the functionality of the mitochondrion, the organelle
where succinate and acetate are formed by these para-
sites (Sánchez-Moreno et al. 1992).
From the data accumulated in the present work and
prior studies (Luque et al. 2000a, b), we conclude that the
triazolo-pyrimidine derivatives represent a potential che-
motherapy against diseases caused by trypanosomes. As
an added advantage, treatment of J-7742 macrophages
with 100 µM of the derivatives for 72 h led to no toxicity to
the mammalian cells (Luque et al. 2000a, b).  Nevertheless,
much work remains to be done in the study of these com-
plexes to gain a full understanding of their functioning,
for example, focusing in more detail on the ultrastructural
changes induced by these derivatives.
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